Sign in

You're signed outSign in or to get full access.

Ramiro Peru

Independent Chair of the Board at Elevance Health
Board

About Ramiro G. Peru

Independent director of Elevance Health (ELV) since 2004; appointed to become Independent Chair of the Board effective at the May 14, 2025 Annual Meeting. Former public-company CFO (Phelps Dodge; Swift Transportation) with deep finance and capital markets expertise, plus oversight experience spanning information systems/technology and human resources; age 69; B.S., University of Arizona. Currently chairs ELV’s Compensation & Talent Committee and serves on the Finance Committee; the Board has determined he is independent under NYSE and SEC standards.

Past Roles

OrganizationRoleTenureCommittees/Impact
Phelps Dodge CorporationExecutive Vice President & Chief Financial Officer; prior finance/accounting roles1979–2007 (CFO 1999–2007)Senior VP responsibilities included managing information systems/technology and human resources; brings operating/technology oversight to boardroom.
Swift CorporationExecutive Vice President & Chief Financial OfficerJun–Dec 2007Public-company CFO experience in transportation/logistics.

External Roles

OrganizationRoleTenurePublic/PrivateNotes
SM Energy CompanyDirectorSince 2014PublicCurrent public company directorship.
UNS Energy Corporation (subsidiary of Fortis Inc.)DirectorSince 2007Private (public until Aug 2014)Long-standing utility governance experience.
bluemedia, Inc.Director2018–2023PrivateLarge-format printing company.
WellPoint Health Networks, Inc.Director2003–2004Public (historical)Historical link to ELV predecessor.

Board Governance

  • Board role and independence: Incoming Independent Chair (effective May 14, 2025); ELV maintains separate Chair/CEO roles; 10 of 11 directors are independent (all except the CEO).
  • Committee assignments: Chair, Compensation & Talent Committee; Member, Finance Committee.
  • Meeting cadence and attendance: 2024 Board meetings (6); independent directors hold executive sessions at the beginning and end of each regularly scheduled Board meeting; each director attended ≥75% of Board and applicable committee meetings in 2024.
  • Committee meeting counts (2024): Audit (8), Compensation & Talent (4), Governance (4), Finance (7).
  • Evaluation, refreshment, leadership: Annual Board/committee/individual director evaluations facilitated by an external party; mandatory retirement age policy; Peru succeeds the retiring Chair in 2025.
  • Risk and oversight: As Compensation & Talent Chair, Peru oversees pay risk reviews, executive pay decisions, talent management and inclusion; the committee uses an independent consultant (WTW), assessed annually for independence.

Fixed Compensation (Non-Employee Director – 2024)

ComponentAmountDetail
Annual cash retainer$125,000Standard non-employee director cash retainer.
Committee chair retainer$30,000Compensation & Talent Committee Chair.
Fees earned or paid in cash (reported)$155,484Includes $483.88 paid in cash in lieu of fractional share.
Annual equity grant (deferred shares) – value$209,516388 deferred shares granted on Annual Meeting date; shares deferred for min. 5 years; dividend equivalents accrue during deferral.
All other compensation$27,613Includes dividend equivalents ($17,613) and eligibility for foundation matching gifts up to $10,000.
Total 2024 director compensation$392,613Sum of cash, equity grant value and other compensation.

Additional policy notes:

  • Non-Executive Chair retainer: $260,000 (applies when serving as Chair; ELV maintains separate Chair/CEO).
  • Director equity grant mechanics: 388 deferred shares in 2024 based on $539.99/share; distribution after 5-year minimum deferral or upon Board departure.

Performance Compensation

  • Non-employee directors at ELV do not receive performance-based incentive pay; compensation is a mix of cash retainers and time-deferred stock awards. No director options outstanding.
  • For context on Peru’s oversight as Compensation & Talent Chair, ELV’s 2024 executive AIP metrics and results were as follows:
Performance MeasureTargetActual 2024 Performance
Adjusted Net Income$8,644 millionMissed threshold: $7,677 million (adjusted).
Operating Revenue$170,200 millionExceeded target: $173,349 million (adjusted).
Improving the Health of Humanity (3 sub-metrics)VariousOverall above target (2 of 3 metrics above target).
Star Ratings+33.5 pp vs. 2023Missed threshold: −2.0 pp vs. 2023.
Consumer Effort+2.0 pp vs. 2023Missed target: +1.9 pp vs. 2023.
  • Relative peer modifier for AIP funding set at 92.5% based on relative Adjusted Net Income growth and Total Revenue growth vs. industry peers.

Other Directorships & Interlocks

  • Current public company board: SM Energy Company (Director since 2014).
  • Compensation committee interlocks: None; during 2024, no ELV executive served on a board or comp committee of another company that had an executive serving on ELV’s Board/Compensation & Talent Committee.
  • Related person transactions: None involving Compensation & Talent Committee members required disclosure under Item 404 in 2024; ELV’s related-person transaction policy requires Governance Committee review/approval and prohibits transactions inconsistent with shareholder interests.

Expertise & Qualifications

  • Finance and capital markets leadership as CFO at two public companies (Phelps Dodge; Swift).
  • Technology and operations oversight experience (managed information systems/technology; board service at an oil & gas E&P with technology oversight).
  • Committee leadership (Compensation & Talent Chair) and incoming Independent Chair—strong governance credentials.
  • Education: B.S., University of Arizona.

Equity Ownership

HolderShares OwnedDeferred SharesTotal Beneficial OwnershipNotes/Date
Ramiro G. Peru6,2672,4778,744Beneficial ownership as of Feb 1, 2025; none of ELV’s directors/NEOs owns ≥1% of shares outstanding.
Director deferred shares outstanding2,477As of Dec 31, 2024, Peru held 2,477 deferred shares under the Board Deferred Compensation Plan.
Ownership guidelinesDirectors must own ≥$625,000 in ELV stock within 5 years; all directors meet or are on track (based on 2024 average price $494.48).
  • Prohibitions on hedging/pledging of ELV stock apply to directors and executive officers.

Governance Assessment

  • Positive signals

    • Independent Board leadership: Separation of Chair/CEO; Peru appointed Independent Chair in 2025; robust independence (10/11 independent directors).
    • Strong compensation governance under Peru’s committee: independent consultant; rigorous AIP and PSU frameworks; clawback policy includes both mandatory restatement-based recovery and discretionary recoupment for misconduct/reputational harm.
    • Shareholder alignment: Annual say-on-pay with strong 2024 support (~92% “for”).
    • Board effectiveness: External-facilitated annual evaluations (board/committee/individual); regular executive sessions; defined committee charters and active meeting cadence.
    • Compliance/ethics: Section 16 filings timely for directors/NEOs (one late Form 4 for a former executive officer due to administrative error).
  • Watch items

    • Consultant conflicts optics: While the Compensation & Talent Committee’s independent advisor (WTW) was deemed independent, ELV and subsidiaries paid WTW and/or subsidiaries ~$177.5 million in 2024 for non-executive services (insurance brokering/marketing), though this represented <2% of WTW parent revenue; continued monitoring advisable.
    • Medicare Star Ratings headwind in 2024 (fell vs. 2023), contributing to below-target AIP funding; oversight focus on remediation remains important.
  • Structural protections

    • No option/SAR repricing without shareholder approval; no change-in-control excise tax gross-ups; double-trigger CIC; anti-hedging/pledging; proxy access; majority voting in uncontested director elections; commitment to declassify if BCBSA requirement ends.
  • Attendance/engagement

    • 2024 attendance at least 75% for all directors; Board met 6x; Peru’s committees met regularly (Compensation & Talent 4x; Finance 7x).